Nitazoxanide dosage and administration: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Nitazoxanide}} {{CMG}}; {{AE}} {{AZ}} ==Dosage And Administration== {| |600PX|THUMB |} A single Alinia tablet contains a greater ...")
 
No edit summary
Line 5: Line 5:
==Dosage And Administration==
==Dosage And Administration==
{|
{|
|[[File:DosageadminAnilia.JPG|600PX|THUMB]]
|[[File:DosageadminAnilia.JPG|400PX|THUMB]]
 
|}
|}



Revision as of 13:06, 9 January 2014

Nitazoxanide
ALINIA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage And Administration

THUMB

A single Alinia tablet contains a greater amount of nitazoxanide than is recommended for pediatric dosing and should therefore not be used in pediatric patients 11 years or younger.

DIRECTIONS FOR MIXING ALINIA FOR ORAL SUSPENSION

Prepare a suspension at time of dispensing as follows: The amount of water required for preparation of the suspension is 48 mL. Tap bottle until all powder flows freely. Add approximately one-half of the total amount of water required for reconstitution and shake vigorously to suspend powder. Add remainder of water and again shake vigorously.

The container should be kept tightly closed, and the suspension should be shaken well before each administration. The suspension may be stored for 7 days, after which any unused portion must be discarded.[1]

References

  1. "ALINIA (NITAZOXANIDE) TABLET ALINIA (NITAZOXANIDE) POWDER, FOR SUSPENSION [ROMARK LABORATORIES, LC]".

Adapted from the FDA Package Insert.